| Application | Comment | Organism |
|---|---|---|
| medicine | role of extracellular granzymes in disease reviewed | Homo sapiens |
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| additional information | inhibited by the extracellular serpins anti-thrombin III and C1-inhibitor and by the non-serpin inhibitor alpha2-macroglobulin | Homo sapiens |
| Localization | Comment | Organism | GeneOntology No. | Textmining |
|---|---|---|---|---|
| extracellular | extracellular functions and mechanisms for escape into the extracellular environment reviewed | Homo sapiens | - |
- |
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | P12544 | - |
- |
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| plasma | - |
Homo sapiens | - |
| Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
|---|---|---|---|
| additional information | - |
detection of extracellular granzyme A during disease reviewed, elevated levels during viral and bacterial infection, arthritis and other diseases | Homo sapiens |
| Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|
| additional information | extracellular substrates of granzyme A and proposed functions summarized, pathological consequences of extracellular granzyme A in disease reviewed, role of anionic interactions in extracellular substrate binding summarized, evidence for the role of glycosaminoglycan-binding sites of granzyme A in extracellular matrix remodelling described | Homo sapiens | ? | - |
? |
| Synonyms | Comment | Organism |
|---|---|---|
| GrA | - |
Homo sapiens |